RxDoctor Payments DataLook up a doctor →

Jose Villasboas Bisneto, MD

Hematology · Rochester, MNNPI 1114155603

Payments from drug & device makers

$5,536,732in general payments, 2019–2025

Across 272 payments — averaging $20,356 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$3.5M
  • Regeneron$1.3M
  • Bristol Myers Squibb$411K
  • Epizyme, Inc.$208K
  • E.r. Squibb & Sons, L.L.C.$133K
  • Gilead$57K
  • plus $4K from 2 others
$23,311in research payments, 2019–2025

Across 46 payments — averaging $506.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$17K
  • F. Hoffmann-la Roche AG$7K

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.106$3,462,933
Regeneron50$1,260,039
Bristol Myers Squibb3$411,203
Epizyme, Inc.96$208,420
E.r. Squibb & Sons, L.L.C.2$133,008
Gilead(2 entities)13$57,283
TG Therapeutics, Inc.1$2,025
Genmab U.S., Inc.1$1,820

How this compares

$5,536,732 in reported general payments places this provider in the 90th percentile of 111 hematology providers in Minnesota.

See all hematology providers in Minnesota

Medicare billing

Part B allowed, 2024
$294,675
Medicare patients
287
Services billed
18,977

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →